| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/25/2007 | US20070020736 producing an oligosaccharide comprising Neu5Ac alpha -3Gal beta -4Glc; culturing a Lac Y+ and NanT+ Escherichia coli microorganism in a medium comprising precursors consisting of lactose and sialylic acid |
| 01/25/2007 | US20070020735 IL-17 homologous polypeptides and therapeutic uses thereof |
| 01/25/2007 | US20070020734 Interferon-alpha polypeptides and conjugates |
| 01/25/2007 | US20070020733 Polypeptide for use in the diagnosis and detection of bacterial infections |
| 01/25/2007 | US20070020732 Inflammatory response protein for use in developing vaccines against allergic diseases; allergic response modulation; antiallergens; signal transducer specifically expressed in human mast cells |
| 01/25/2007 | US20070020731 Thermostable amylase polypeptides, nucliec acids encoding those polypeptides and uses thereof |
| 01/25/2007 | US20070020730 Method for overexpression of zwitterionic polysaccharides |
| 01/25/2007 | US20070020729 Novel collectin |
| 01/25/2007 | US20070020728 Muteins of apolipoprotein D |
| 01/25/2007 | US20070020727 Non-maltogenic glycosidase for improving storage stabilty of baked goods |
| 01/25/2007 | US20070020726 Novel glutaminase, its gene and a method of producing it |
| 01/25/2007 | US20070020725 Prokaryotically produced antibodies and uses thereof |
| 01/25/2007 | US20070020724 94 human secreted proteins |
| 01/25/2007 | US20070020723 Ceramide kinase-like proteins |
| 01/25/2007 | US20070020722 Telomere elongation |
| 01/25/2007 | US20070020714 Biosensor with increased signal intensity to sugar concentration that is a maltose binding protein bound to enhanced cyan, enhanced blue, or enhanced green fluorescent protein on one end and enhanced yellow, enhanced green, or red fluorescent protein on the other through dipeptide linkages |
| 01/25/2007 | US20070020709 IGF binding proteins |
| 01/25/2007 | US20070020708 Nucleotide sequences coding regulatory proteins comprising death domains for identifying modulators of nuclear factor kappa beta activity and treatments for cell proliferative and neurodegenerative diseases; gene expression inhibition |
| 01/25/2007 | US20070020706 Truncated proteins as cancer markers |
| 01/25/2007 | US20070020698 IGF binding proteins |
| 01/25/2007 | US20070020695 Immunogenic peptide sequences; antibodies directed against particular amino acid regions of Hsp70B' |
| 01/25/2007 | US20070020686 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 01/25/2007 | US20070020685 Secretion of antibodies without signal peptides from bacteria |
| 01/25/2007 | US20070020680 Nucleic acid marker ladder for estimating mass |
| 01/25/2007 | US20070020679 Modulation of HIF1alpha and HIF2alpha expression |
| 01/25/2007 | US20070020678 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides |
| 01/25/2007 | US20070020675 Modulation of endothelial lipase expression |
| 01/25/2007 | US20070020674 Novel gene defective in APECED and its use |
| 01/25/2007 | US20070020667 Methods and compositions for amplifying nucleic acids |
| 01/25/2007 | US20070020664 Light emission modifiers and their uses in nucleic acid detection, amplification and analysis |
| 01/25/2007 | US20070020659 Screening for agents that disrupt protein-DNA interactions;Inhibition of topoisomerase IV results in the in vivo production of supercoiled minicircles |
| 01/25/2007 | US20070020656 Snapback oligonucleotide probe |
| 01/25/2007 | US20070020653 DNA polymerase |
| 01/25/2007 | US20070020652 Methods and compositions for RNA interference |
| 01/25/2007 | US20070020643 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered |
| 01/25/2007 | US20070020637 Full-length cDNA |
| 01/25/2007 | US20070020635 Nucleotides for prevention and treatment of bacterial and fungal pathologies |
| 01/25/2007 | US20070020634 Polynucleotide sequence transcribed from a complementary polynucleotide sequence thereof; glutamyl O-tRNA suppresses in the presence of a tRNA synthetase (RS) selected from Archaeoglobus fulgidus, Methanosarcina mazei synthetase, Methanobacterium thermoautotrophicum, and Pyrococcus horikoshii synthetase |
| 01/25/2007 | US20070020633 Treatment of nucleic acid |
| 01/25/2007 | US20070020632 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) |
| 01/25/2007 | US20070020627 Artificial transcription factors |
| 01/25/2007 | US20070020625 Sequence of the photorhabdus luminescens strain tt01 genome and uses |
| 01/25/2007 | US20070020624 Nucleic acid and amino acid sequences relating to Pseudomonas aeruginosa for diagnostics and therapeutics |
| 01/25/2007 | US20070020622 DNA Polymerases and mutants thereof |
| 01/25/2007 | US20070020621 Rice genomic promoter sequences; suited for use in rice and other cereal crops |
| 01/25/2007 | US20070020286 Recombinant constructs of Borrelia burgdorferi |
| 01/25/2007 | US20070020285 prophylactic and therapeutic vaccination directed against the hepatitis C virus |
| 01/25/2007 | US20070020284 decreased protein degradation, increased stability and circulation time; for excess weight, diabetes, high blood lipid level, arteriosclerosis, arterial plaque, the reduction or prevention of gall stones formation, insufficient lean tissue mass, insufficient sensitivity to insulin, and stroke |
| 01/25/2007 | US20070020283 Fusion protein; multimeric protein; treating interferon gamma -related conditions |
| 01/25/2007 | US20070020277 Human Oncogene Induced Secreted Protein I |
| 01/25/2007 | US20070020276 Methods for the treatment of carcinoma |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 01/25/2007 | US20070020273 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 01/25/2007 | US20070020270 Human serpin polypeptides |
| 01/25/2007 | US20070020269 Phosphokinase and the usage thereof |
| 01/25/2007 | US20070020268 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | US20070020259 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases |
| 01/25/2007 | US20070020257 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 01/25/2007 | US20070020251 Administering to the cell all or part of a peptide isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for inhibiting calcium uptake by a cancer cell |
| 01/25/2007 | US20070020235 Interferon-alpha polypeptides and conjugates |
| 01/25/2007 | CA2782619A1 Compositions and methods relating to orthogonal ribosome mrna pairs |
| 01/25/2007 | CA2551906A1 Methods and reagents for detecting target nucleic acids |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1745573A2 METHODS OF MANUFACTURE OF 2 -DEOXY-&bgr;-L-NUCLEOSIDES |
| 01/24/2007 | EP1745156A2 Methods for detecting chromosome aberrations |
| 01/24/2007 | EP1745129A2 Canine pancreatic lipse |
| 01/24/2007 | EP1745063A1 Method for producing chemical microarrays |
| 01/24/2007 | EP1744788A2 Combinatorial methods and compositions for treatment of melanoma |
| 01/24/2007 | EP1744779A2 Lytic enzymes and spore surface antigen for detection and treatment of "bacillus anthracis" bacteria and spores |
| 01/24/2007 | EP1744619A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/24/2007 | EP1687419A4 Hybrid enzymes |
| 01/24/2007 | EP1590478A4 Rna bioassay |
| 01/24/2007 | EP1337665B1 Immobilization of biopolymers to aminated substrates by direct adsorption |
| 01/24/2007 | EP1334111A4 Phosphinoamidite carboxylates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge |
| 01/24/2007 | EP1123414B1 Antisense modulation of integrin alpha 4 expression |
| 01/24/2007 | EP0760000B1 Alphavirus expression vector |
| 01/24/2007 | CN1902311A Novel recombinant proteins with n-terminal free thiol |
| 01/24/2007 | CN1902310A Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 01/24/2007 | CN1902231A CD20 antibodies with increased Fc receptor binding affinity and effector function |
| 01/24/2007 | CN1902229A IL-18 binding proteins |
| 01/24/2007 | CN1902227A TIM-3 ligands and methods thereof |
| 01/24/2007 | CN1901931A HIV gp41 hr2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus |
| 01/24/2007 | CN1900282A Soy bean cyst roundworm specific SCAR label, specific primer and quick PCR detecting method |
| 01/24/2007 | CN1296378C CpG-N ODN gene sequence with high immunological activity CpG-S ODN and antagonism CpG-N ODN and use thereof |
| 01/23/2007 | US7167802 Methods for identifying agents that interact with MAP kinase activated protein kinase 2 |
| 01/23/2007 | US7166771 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 01/23/2007 | US7166769 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants |
| 01/23/2007 | US7166718 Calix[4]arene-nucleoside and calix[4]oligonucleotide hybrids |
| 01/23/2007 | US7166717 Nucleic acids encoding β 1,4-N-acetylgalactosaminyltransferases from C. jejuni |
| 01/23/2007 | US7166716 Nucleotide sequences coding phosphoinositide 3-kinase related kinases (PIKKs) for use in identifying modulator for use in treatment of cell proliferative disorders |
| 01/23/2007 | US7166715 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 01/23/2007 | US7166714 Polynucleotide encoding a STEAP-1 polypeptide, used for diagnosis and treatment of prostate cancer |
| 01/23/2007 | US7166713 Comprises nucleotide sequences coding cleavage stimulation factor (hCstF) for diagnosing male infertility and cancer; contraceptive |
| 01/23/2007 | US7166702 Used to treat inflammatory responses associated with activation, proliferation and migration of immune effector cells, including leukocyte cell types, neutrophils, macrophages, and eosinophils |
| 01/23/2007 | US7166698 Mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes |
| 01/23/2007 | US7166692 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 01/23/2007 | US7166574 Have a hydrophobic linker region and a heparin-binding region, useful as soluble biologics or as surface coatings for medical devices |
| 01/23/2007 | US7166478 Cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes; useful for labeling probes or targets, including nucleic acids and proteins |
| 01/23/2007 | US7166466 Method for creating polynucleotide and polypeptide sequences |